The Imapact of Paracetamol on the Excretory System: A Review of Toxicity and Protective Strategies
DOI:
https://doi.org/10.26438/ijsrbs.v12i2.674Keywords:
Paracetamol, Histological alteration, Biochemical analysis, Oxidative stress enzymes, Urine and plasma analysis, Mitigating agentAbstract
Paracetamol, a painkiller and antipyretic, works well for pain and fever. But its availability and perceived safety puts us at risk of accidental overdose which can cause liver damage, kidney failure, and other side effects. Paracetamol works by inhibiting COX-2 enzymes, reducing prostaglandin production, and targeting the hypothalamus to relieve pain, inflammation, and fever. But overdose can cause severe kidney damage and impairment leading to acute and chronic renal dysfunction. Studies have shown that paracetamol administration can cause nephrotoxicity characterized by histopathological changes, oxidative damage, and apoptosis. Long term and repeated intake can cause kidney dysfunction, damage, and ultrastructure defects. Fortunately, several compounds have been found to counteract paracetamol’s toxic effects including Nigella sativa, nitric oxide, alpha- lipoic acid, quercetin, curcumin, and antioxidants. These substances have been shown to reduce oxidative stress, inflammation, and kidney damage caused by paracetamol overdose. In summary, while paracetamol is widely used as an effective painkiller, its potential for overdose and toxicity requires cautious use and awareness of the risks. The identification of compounds that can counteract paracetamol’s toxic effects is a promising avenue to reduce paracetamol-induced kidney damage and safe treatment.
References
N. Cranswick, D. Coghlan, "Paracetamol efficacy and safety in children: the first40years," American Journal of Therapeutics, Vol.7, Issue.2, pp.135-141, 2000.
Y. Song, Y. Zhang, J. Li, C. Tan, Y. Li, "Preparation of poly ionic liquid-mesoporous carbon nanospheres and its application in the simultaneous determination of hydroquinone and catechol, and detection of paracetamol," Journal of Electroanalytical Chemistry, Vol.865, Article.114157, 2020.
J.A. Hinson, D.W. Roberts, L.P. James, "Mechanisms of Acetaminophen Induced Liver Necrosis," Handbook of Experimental Pharmacology, Vol.196, pp.369-405, 2010.
I.M. Iloamaeke, K.O. Iwuozor, "Quality assessment of selected paracetamol tablets sold at Bridge Head Market, Onitsha, Anambra state, Nigeria," British Journal of Pharmaceutical and Medical Research, Vol.3, Issue.5, pp.1190-1197, 2018.
O. Ozkaya, G. Genc, K. Bek, Y. Sullu, "A case of acetaminophen (paracetamol) causing renal failure without liver damage in a child and review of literature," Renal Failure, Vol.32, Issue.9, pp. 1125-1127, 2010.
V. Rodenas, M.S. Garcia, C. Sanchez-Pedreno, M.I. Albero, "Simultaneous determination of propacetamol and paracetamol by derivative spectrophotometry," Talanta, Vol.52, Issue.3, pp.517-523, 2000.
T.J. Athersuch, D.J. Antoine, A.R. Boobis, M. Coen, A.K. Daly, "Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective," Toxicology Research, Vol.7, Issue.3, pp.347-357, 2018.
H.K.H. Lee, M. Ting, F.L. Lau, "A randomised control trial comparing the efficacy of tramadol and paracetamol against ketorolac and paracetamol in the management of musculoskeletal pain in the emergency department", Hong Kong Journal of Emergency Medicine, Vol.15, Issue.1, pp.5-11, 2008.
F.F. Daly, J.S. Fountain, L. Murray, A. Graudins, N.A. Buckley, "Guidelines for the management of paracetamol poisoning in Australia and New Zealand explanation and elaboration," The Medical Journal of Australia, Vol.188, Issue.5, pp.296-301, 2008.
A. Fritz, D. Busch, J. Lapczuk, M. Ostrowski, M. Drozdzik, S. Oswald, "Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis," Basic & Clinical Pharmacology & Toxicology, Vol.124, Issue.3, pp. 245-255, 2019.
S. Jefferies, M. Saxena, P. Young, "Paracetamol in critical illness: a review," Critical Care and Resuscitation, Vol.14, Issue.1, pp.74–80, 2012.
C.I. Ghanem, M.J. Perez, J.E. Manautou, A.D. Mottino, "Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity," Pharmacological Research, Vol.109, pp.119-131, 2016.
B. Kis, J.A. Snipes, D.W. Busija, "Acetaminophen and the cyclooxygenase-3puzzle: Sorting out facts, fictions, and uncertainties," The Journal of Pharmacology and Experimental Therapeutics, Vol.315, Issue.1, pp.1–7, 2005.
C. Lorz, P. Justo, A. Sanz, D. Subira, J. Egido, A. Ortiz, "Paracetamol-induced renal tubular injury: a role for ER stress," Journal of the American Society of Nephrology, Vol.15, Issue.2, pp.380-389, 2004.
I. Topal, M.Y. Ozdamar, T. Catakli, et al., "Reno protective effect of taxifolin in paracetamol induced nephrotoxicity: emerging evidence from an animal model," Journal of Clinical Medicine, Vol.12, Issue.3, pp.876, 2023.
J. Das, J. Ghosh, P. Manna, P.C. Sil., "Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation, "Toxicology, Vol.269, Issue.1, pp.24-34, 2010.
D. Canayakin, Y. Bayir, N.K. Baygutalp, E.S. Karaoglan, H.T. Atmaca, et al., "Paracetamol-induced nephrotoxicity and oxidative stress in rats: the protective role of Nigella sativa," Pharmaceutical Biology, Vol.54, Issue.10, pp.2082–2091, 2016.
H. Mohamed, A. Ahmed, J. Richard, A. Balment, "Renal action of acute chloroquine and paracetamol administration in the anesthetized, fluid balanced rat," The Journal of Pharmacology and Experimental Therapeutics, Vol.306, pp.478-483, 2003.
A. Whelton, G. Schulman, C. Wallemark, J. Drower, C. Isakson, et al., "Effects of celecoxib and naproxen on renal function in the elderly," Archives of Internal Medicine, Vol.160, Issue.10, pp.1465-1470, 2000.
I. Krause, R. Cleper, B. Eisenstein, M. Davidovits, "Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy children," Pediatric Nephrology (Berlin, Germany), Vol.20, Issue.9, pp.1295–1298, 2005.
K. Heard, V.E. Anderson, E.J. Lavonas, R.C. Dart, J.L. Green, "Serum paracetamol- protein adducts in ambulatory subjects: Relationship to recently reported paracetamol use," Biomarkers, Vol.23, Issue.3, pp.288–292, 2018.
S. Makhdoom, A. Maqbool, H. Muhammad, M. Makhdoom, H. Ashraf, W.A. Khan, M. Irfan, "Nephrocurative effect of Parthenium heterophorias (Carrot Grass) in paracetamol induced nephrotoxicity in rabbits," Cellular and Molecular Biology (Noisy-le-Grand, France), Vol.68, Issue.7, pp.33–39, 2022.
M.R. McGill, M.R. Sharpe, C.D. Williams, M. Taha, S.C. Curry, H. Jaeschke, "The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation," The Journal of Clinical Investigation, Vol.122, Issue.4, pp.1574-1583, 2012.
H.F. Karaali, R.R. Fahmi, J.M. Borjac, "Effect of Ocimum basilicum leaves extract on acetaminophen-induced nephrotoxicity in BALB/c mice," Journal of Complementary and Integrative Medicine, Vol.16, Issue.2, pp.20180111, 2019.
Y. Chilliard, A. Ferlay, M. Doreau, "Effect of different types of forages, animal fat or marine oils in cow’s diet on milk fat secretion and composition, especially conjugated linoleic acid (CLA) and polyunsaturated fatty acids," Livestock Production Science, Vol.70, pp.31-48, 2001.
C.M. Fored, E. Ejerblad, P. Lindblad, P. Fryzek, P.W. Dickman, et al., "Acetaminophen, aspirin, and chronic renal failure," The New England Journal of Medicine, Vol.345, Issue.25, pp.1801-1808, 2001.
J.R. Graham, C.R. Harvey, S. Rajgopal, "The economic implications of corporate financial reporting," Journal of Accounting and Economics, Vol.3, pp.73, 2005.
J.R. Brown, R.N. DuBois, "COX-2: a molecular target for colorectal cancer prevention," Journal of Clinical Oncology, Vol.23, Issue.12, pp.2840-2855, 2005.
P.J. Wild, L.A. Kunz-Schughart, R. Stoehr, M. Burger, H. Blaszyk, R. Simon, T. Gasser, M. Mihatsch, G. Sauter, A. Hartmann, "High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer," International Journal of Oncology, Vol.27, Issue.2, pp.385- 391, 2005.
J.E. Castelao, J.M. Yuan, M. Gago-Dominguez, M.C. Yu, R.K. Ross, "Nonsteroidal anti-inflammatory drugs and bladder cancer prevention," British Journal of Cancer, Vol.82, Issue.7, pp.1364-1369, 2000.
J.A. Kaye, M.W. Myers, H. Jick, "Acetaminophen and the risk of renal and bladder cancer in the general practice research database," Epidemiology, Vol.12, Issue.6, pp.690-694, 2001.
E. Oksuz, M.S. Bugday, "Can intravesical application of paracetamol benefit the chemotherapy treatment of bladder cancer?," Medical Hypotheses, Vol.131, pp.109322, 2019.
J. Fortuny, M. Kogevinas, M. Garcia-Closas, F.X. Real, A. Tardon, R. Garcia-Closas, et al., "Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain," Cancer Epidemiology, Biomarkers and Prevention, Vol.15, Issue.9, pp.1696-1702, 2006.
W. Allam, S. Kasem, S. Mahmoud, A. Abdallah, M. Hilal, "Experimental study of the possible protective effect of alpha-lipoic acid on paracetamol induced oxidative stress and hepatic toxicity in albino rats," Ani Shams Journal of Forensic Medicine and Clinical Toxicology, Vol.36, Issue.1, pp.75-89, 2021.
B.A. Abdullah, S. Wadee, E. Sarhat, "Histological study effects of paracetamol on livers and kidneys of adult mice," Journal of Tikrit University for Agriculture Sciences, Vol.17, Issue.6, pp.28-29, 2017.
H. Muddasir, M. Abbasi, K. David, M. Idnan, "Effect of time-lapse administration of panadol (paracetamol) on spleen and kidney functions of adult albino mice," RADS Journal of Biological Research & Applied Science, Vol.9, Issue.2, 2018.
J.A. Neto, R.M. Oliveira-Filho, M.J. Simoes, J.M. Soares, L. Kulay, "Long term acetaminophen (paracetamol) treatment causes liver and kidney ultra-structural changes during rat pregnancy," Clinical and Experimental Obstetrics Gynecology, Vol.31, Issue.3, pp.221-224, 2004.
R.E. Ucheya, J.C. Igweh, "Histological changes in kidney structure following a long-term administration of paracetamol (acetaminophen) in pregnant Sprague Dawley rats," Nigerian Journal of Physiological Sciences, Vol.21, Issues.1-2, pp.77-81, 2006.
M.I. Yousef, S.A.M. Omar, M.I. El-Guendi, LA. Abdelmegid, "Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and hematotoxicity in rat," Food and Chemical Toxicology, Vol.48, Issue.11, pp.3246-3261, 2010.
L. Fadda, H.M. Ali, G.A. Aldrees, N.M. Alquraishi, "Nano ubiquinone: promising candidate for treatment of renal toxicity induced by overdose of paracetamol," Toxicology Reports, Vol.6, pp.712-717, 2019.
S.J. Offor, S.O.J. Akpan, A.A. Tologbonse, R.A. Umoh, D.F. Akpan, "Ameliorating effects of Solanum anomalum Thonn. Ex. Schumach fruit extracts on paracetamol induced kidney injuries and haemato-biochemical indices in rats," Journal of Complementary and Alternative Medical Research, Vol.17, Issue.1, pp.37-45, 2022.
Q. Oloo, "The effects of paracetamol on the liver and kidney functions of a rat model following prolonged alcohol administration," Journal of Drug Metabolism and Toxicology, Vol.12, Issue.2, 2021.
E. Karatas, Z. Bayraktutan, E. Cadirci, "Investigation of the effects of amlodipine on paracetamol-induced acute kidney toxicity in rats," Clinical and Experimental Health Science, Vol.12, Issue.1, pp.155-161, 2021.
F. Topal, M. Topal, H. Gocer, P. Kalin, et al., "Antioxidant activity of taxifolin: an activity-structure relationship," Journal of Enzyme Inhibition and Medicinal Chemistry, Vol.31, Issue.4, pp.1-10, 2015.
Z. Marchewka, M. Przewłocki, M. Lepka, A. Długosz, K. Kochman, "[Selected biochemical parameters of urine in the evaluation of paracetamol nephrotoxicity]," Przeglad Lekarski, Vol.63, Issue.12, pp.1299-1303, 2006.
L.S. Jensen, J. Valentine, R.W. Milne, A.M. Evans, "The quantification of paracetamol, paracetamol glucuronide and paracetamol sulfate in plasma and urine using a single high-performance liquid chromatography assay," Journal of Pharmaceutical and Biomedical Analysis, Vol.34, Issue.3, pp.585-593, 2004.
A.K. Hewavitharana, S.J. Lee, T. Parkar, D. Markovich, P.J. Shaw, "Development of an HPLC-MS/MS method for the selective determination of paracetamol metabolites in mouse urine," Analytical Biochemistry, Vol.374, Issue.1, pp.106-111, 2008.
P. Soysa, S. Kolambage, "Rapid HPLC/UV method for analysis of urinary and plasma/serum paracetamol concentrations," Journal of the National Science Foundation of Sri Lanka, Vol.38, Issue.2, 2010.
A. Dominguez, F.J. Lopez-Munoz, J.R.M. Lopez, M.H.Y. de la Pena, "HPLC-PDA method for the quantification of paracetamol in plasma: application to PK/PD studies with arthritic rats," International Journal of Pharmacy and Pharmaceutical Sciences, Vol.9, Issue.5, pp.233, 2017.
M. Lecoeur, G. Rabenirina, N. Schifano, P. Odou, S. Ethgen, et al., "Determination of acetaminophen and its main metabolites in urine by capillary electrophoresis hyphenated to mass spectrometry," Talanta,Vol.205, 2019.
W. Xue, Y. Xie, Q. Wang, W. Xu, S. Mou, Z. Ni, "Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient," Nephrology (Carlton, Vic.), Vol.19, Issue.4, pp.186-194, 2014.
N. Pakravan, D.N. Bateman, J. Goddard, "Effect of acute paracetamol overdose on changes in serum and urine electrolytes," British Journal of Clinical Pharmacology, Vol.64, Issue.6, pp.824-832, 2007.
S. Chang, T. Mathew, S. McDonald, "Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes," Clinical Journal of the American Society of Nephrology, Vol.3, Issue.3, pp.768-776, 2008.
M. Saleem, H. Iftikhar, "A rare case of acetaminophen toxicity leading to severe kidney injury," Cureus, Vol.11, Issue.6, 2019.
Z. Khan, M. Abumedian, M. Ibekwe, K. Musa, G. Mlawa, "Acute renal impairment in patients due to paracetamol overdose in the absence of hepatic impairment," Cureus, Vol.13, Issue.12, 2021.
A.M. Roshdi, O.A.A. Hassan, M.B. Ahmed, A.S. Abd-El Azeem, "Evaluation of the impact of an acute single paracetamol overdose on renal functions and serum electrolytes," Minia Journal of Medical Research, Vol.35, Issue.2, pp.72-79, 2024.
E.M. Strehle, I. Haar, "Acute kidney injury after treatment of paracetamol overdose using new N-acetylcysteine guideline," Archives of Disease in Childhood, Vol.108, Issue.5, pp.416-417, 2023.
M. Kelkar, M.A. Cleves, H.R. Foster, W.R. Hogan, L.P. James, B.C. Martin, "Acute and chronic acetaminophen use and renal disease: a case-control study using pharmacy and medical claims," Journal of Managed Care Pharmacy, Vol.18, Issue.3, pp.234-246, 2012.
S.W. Lines, A. Wood, M.C. Bellamy, A.J. Lewington, "The outcomes of critically ill patients with combined severe acute liver and kidney injury secondary to paracetamol toxicity requiring renal replacement therapy," Renal Failure, Vol.33, Issue.8, pp.785-788, 2011.
A. O'Riordan, Z. Brummell, E. Sizer, G. Auzinger, N. Heaton, et al., "Acute kidney injury in patients admitted to the liver intensive therapy unit with paracetamol-induced hepatotoxicity, "Nephrology, Dialysis, Transplantation, Vol.26, Issue.11, pp.3501–3508, 2011.
D.J. Antoine, V.S. Sabbisetti, B. Francis, A.L. Jorgensen, D.G.N. Craig, et al., "Circulating kidney injury molecule 1 predicts prognosis and poor outcome in patients with acetaminophen-induced liver injury," Hepatology, Vol.62, Issue.2, pp.591-599, 2015.
S. Aksun, A. Gokcimen, F. Kahyaoglu, B. Demirci, "The effect of paracetamol exposure on hepatic and renal tissues during statin usage," Turkish Journal of Biochemistry, Vol.44, Issue.1, pp.113-120, 2019.
T.K. Motawi, S.A. Ahmed, N.A. El-Boghdady, N.S. Metwally, N.N. Nasr, "Protective effects of betanin against paracetamol and diclofenac induced neurotoxicity and endocrine disruption in rats," Biomarkers, Vol.24, Issue.7, pp.645-651, 2019.
N. Sohail, M. Azam, H. Farhat, K. Hira, F. Urooj, et al., "Ulva fasciata, a green alga, attenuates the kidney and liver dysfunctions in rats induced by acetaminophen," Drug and Chemical Toxicology, Vol.47, Issue.1, pp.1-14, 2022.
A.O. Abdel-Zaher, R.H. Abdel-Hady, M.M. Mahmoud, M.M.Y. Farrag, "The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage," Toxicology, Vol.243, Issue.3, pp.261-270, 2008.
A.O. Abdel-Zaher, M.M. Abdel-Rahman, M.M. Hafez, F.M. Omran, "Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage," Toxicology, Vol.234, Issues.1-2, pp.124-134, 2007.
F.M. Kandemir, S. Kucukler, E. Eldutar, C. Caglayan, I. Gülçin, "Chrysin protects rat kidney from paracetamol-induced oxidative stress, inflammation, apoptosis, and autophagy: a multi-biomarker approach," Scientia Pharmaceutica, Vol.85, Issue.1, pp.4, 2017.
O. Abdalally, E. Alshailabi, M. Saleh "Effects of vitamin C on liver and kidney enzymes and some biochemical parameters against paracetamol-induced hepatic nephrotoxicity in rats," Sirte University Scientific Journal (Applied Sciences), Vol.12, Issue.2, 2021.
O. Baponwa, A.P. Amang, C. Mezui, B.B. Koubala, G.T. Siwe, V.L. Vandi, P.V. Tan, "Antioxidant mechanism of renal and hepatic failure prevention related to paracetamol overdose by the aqueous extract of Amblygonocarpus andongensis stem bark," BioMed Research International, Vol.2022, pp.16, 2022.
Y. Si, L. Liu, Y. Zhang, H. Li, T. Zhao, S. Liu, X. Sun, J. Cheng, H. Lu, "Magnesium hydride protects against acetaminophen-induced acute kidney injury by inhibiting TXNIP/NLRP3/nf-κb pathway," Renal Failure, Vol.46, Issue.1, 2024.
S. Sahin, A.C. Aydın, A.Y. Gocmen, E. Kaymak, "Evaluation of the protective effect of losartan in acetaminophen-induced liver and kidney damage in mice," Naunyn-Schmiedeberg’s Archives of Pharmacology, Vol.397, Issue.7, pp.5067-5078, 2024.
J.Y. Akakpo, A. Ramachandran, H. Orhan, S.C. Curry, B.H. Rumack, H. Jaeschke, "4-methylpyrazole protects against acetaminophen-induced acute kidney injury," Toxicology and Applied Pharmacology, Vol.409, Article.115317, 2020.
J. Ghosh, J. Das, P. Manna, P.C. Sil, "Acetaminophen-induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid", Toxicology, Vol.268, Issues.1-2, pp.8-18, 2010.
Z. Abdul Hamid, S.B. Budin, N. Wen Jie, A. Hamid, K. Husain, J. Mohamed, "Nephroprotective effects of Zingiber zerumbet Smith ethyl acetate extract against paracetamol-induced nephrotoxicity and oxidative stress in rats," Journal of Zhejiang University SCIENCE B, Vol.13, Issue.3, pp.176-185, 2012.
M. Srabovic, M. Huremovic, B. Catovic, S. Muratovic, A. Taletović, “Design synthesis and crystallization of acetaminophen,” Journal of Chemical, Biological and Physical Sciences, Vol.7, No.1, pp.218-230, 2017.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Punam Bante , Shikha Sethiya, Mangala Thakare, Dr.Varsha Dhurvey

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit and that in the event of reuse or distribution, the terms of this license are made clear.